HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postoperative adjuvant therapy.

Abstract
After a lengthy search for an effective treatment for resected pancreatic cancer, evidence accumulated in the past 10 years shows that adjuvant chemotherapy is firmly established as offering a modest but real improvement in overall survival. However, the optimal choice of treatment modality (chemotherapy with or without radiation therapy) remains highly controversial. Results from ongoing studies will further optimize the treatment over the next decade.
AuthorsTomoo Kosuge, Yoshihiro Sakamoto, Hideki Ueno
JournalJournal of hepato-biliary-pancreatic sciences (J Hepatobiliary Pancreat Sci) Vol. 18 Issue 6 Pg. 792-6 (Nov 2011) ISSN: 1868-6982 [Electronic] Japan
PMID21874279 (Publication Type: Journal Article, Review)
Copyright© 2011 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Topics
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Humans
  • Pancreatic Neoplasms (therapy)
  • Radiotherapy, Adjuvant
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: